Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Ousehold in China
Status:
Recruiting
Trial end date:
2023-05-15
Target enrollment:
Participant gender:
Summary
A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and
Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals
Infected with SARS-CoV-2 in China